3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gastrointestinal
1
Conditions
Prostatic Neoplasms
3
Precancerous Conditions
3
Rectal Neoplasms
1
Lung Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Adenomatous Polyps
1
Interventions
Oxaliplatin
21
Fluorouracil
20
Leucovorin
19
Capecitabine
18
Irinotecan
13
Radiotherapy
8
Bevacizumab
7
Cetuximab
6
Folfox protocol
4
cediranib
2
Radiation
2
Psychiatric Rehabilitation
2
Octreotide
2
Cisplatin
2
Chemoradiotherapy
2
tipifarnib
1
pertuzumab
1
olaparib
1
mercaptoundecahydrododecaborate
1
eniluracil
1
durvalumab
1
brivanib
1
alpha-Tocopherol
1
Watchful Waiting
1
Vitamin E
1
Trastuzumab
1
Tegafur
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Standard of Care
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Rectal Neoplasms
×
Selenium
×
Clear all
NCT00706121
2019-12-16
ACP
SWOG Cancer Research Network
Phase 3
Completed
8,094 enrolled
23 charts